Journal Guides5 min readUpdated May 16, 2026

Clinical Infectious Diseases 'Under Review': What Each Status Means and When to Expect a Decision

If your Clinical Infectious Diseases submission shows Under Review, here is what each status means, how long each stage typically takes, and when to follow up.

Author contextAssociate Professor, Immunology & Infectious Disease. Experience with Immunity, Nature Immunology, Journal of Experimental Medicine.View profile

What to do next

Already submitted to Clinical Infectious Diseases? Use this page to interpret the status and choose the next step.

The useful next step is understanding what the status usually means at Clinical Infectious Diseases, how long the wait normally runs, and when a follow-up is actually reasonable.

See The Next StepAnthropic Privacy Partner. Zero-retention manuscript processing.Run Free Readiness ScanOr check your bibliography for retracted citations
Timeline context

Clinical Infectious Diseases review timeline: what the data shows

Time to first decision is the most actionable number. What happens after varies by manuscript and reviewer availability.

Full journal profile
Time to decision~90-120 days medianFirst decision
Acceptance rate~25-35%Overall selectivity
Impact factor7.3Clarivate JCR

What shapes the timeline

  • Desk decisions are fast. Scope problems surface within days.
  • Reviewer availability is the main variable after triage. Specialized topics take longer to assign.
  • Revision rounds reset the clock. Major revision typically adds 6-12 weeks per round.

What to do while waiting

  • Track status in the submission portal — status changes signal active review.
  • Wait at least the journal's stated median before sending a status inquiry.
  • Prepare revision materials in parallel if you expect a revise-and-resubmit decision.

_Last reviewed: 2026-05-16._

Quick answer: If your Clinical Infectious Diseases (CID) manuscript shows "Under Review," elapsed time is the reliable signal. Clinical Infectious Diseases has a 2024 JCR impact factor of 11.8, accepts about 20 percent of submissions, and reports a median first-decision time of 4 to 8 weeks. If still Under Review past 2 weeks, you have likely cleared the initial editorial screen.

Submission portal and editorial contact: Clinical Infectious Diseases uses OUP ScholarOne at mc.manuscriptcentral.com/cid. Editorial questions go through the OUP author portal at journals.permissions@oup.com, referencing the manuscript ID.

CID desk-rejects roughly 50 to 60 percent of submissions in 7 to 14 days. If past that window, peer review is active.

While you wait

You can't speed up CID's review. A CID submission readiness check flags clinical-relevance gaps, methodology issues, and reporting-checklist completeness that drive most desk rejections, in about 5 minutes.

CID's review pipeline

Status
What is happening
Typical duration
Submitted to Journal
Administrative processing
Day 0 to 2
With Editor
Editor evaluating desk-screen fit
Days 2 to 14
Under Review
Reviewers invited or actively reviewing
Days 14 to 56
Required Reviews Complete
Editor synthesizing reports
5 to 10 days
Decision in Process
Editor finalizing decision letter
3 to 7 days
Decision Sent
Reject, R&R, or accept
Check email

The editorial desk screen (about 50 to 60 percent rejected)

CID editors evaluate clinical-ID relevance, methodology rigor, and IDSA-audience fit. A desk rejection usually means scope (better fit for a sister IDSA or ID journal), methodology gaps, or weak clinical-decision impact.

Day 0: ScholarOne upload

The mc.manuscriptcentral.com/cid portal accepts the package and routes to an Associate Editor matching the ID subfield.

Days 1 to 14: Editor desk-screen

The handling editor reads the paper, evaluates clinical-ID relevance and methodology, and decides whether to invite reviewers.

Days 14 to 28: Reviewer invitations

CID typically invites two to three reviewers including an ID clinician and a methodologist.

Days 21 to 56: Peer review

Reviewer reports return on a 4 to 8 week cadence.

Days 56 to 84: First editorial decision

Major revision is the most common outcome.

Days 84 to 240: Revision rounds and acceptance

Single-revision acceptances run roughly 4 to 6 months.

When to worry

  • Rejection within 1 to 5 days: Administrative issue or scope mismatch.
  • Rejection within 7 to 14 days: Desk rejection.
  • Still Under Review after 3 weeks: Good sign.
  • Still Under Review after 10 weeks: Reviewer delay.

Readiness check

While you wait on Clinical Infectious Diseases, scan your next manuscript.

The scan takes about 1-2 minutes. Use the result to decide whether to revise before the decision comes back.

Check my next manuscriptAnthropic Privacy Partner. Zero-retention manuscript processing.Open status guideOr verify a citation in 10 seconds

What to do while waiting

  • Do not contact the editorial office during the first 8 weeks unless urgent.
  • Prepare a point-by-point response template focused on clinical relevance, methodology details, and reporting-checklist items.

How CID compares to nearby alternatives

Feature
CID
Lancet Infectious Diseases
Journal of Infectious Diseases
Open Forum Infectious Diseases
Desk rejection rate
50 to 60 percent
70 to 80 percent
40 to 50 percent
30 to 40 percent
Desk decision speed
7 to 14 days
5 to 10 days
7 to 14 days
14 to 21 days
Total review time
4 to 8 weeks
8 to 12 weeks
4 to 8 weeks
6 to 10 weeks
Editorial bar
Top clinical ID with practice implications
Highest-impact ID with global health
Mechanism-and-translational ID
Open-access ID with broad scope

Submit if your paper passed the desk

If your CID paper is Under Review past 2 weeks, you have likely cleared the desk screen.

CID submission readiness check. It takes about 1-2 minutes.

Think twice before assuming "Under Review" means safe

CID editors retain discretion to reject after partial review. Our CID manuscript fit check flags clinical-relevance gaps before reviewers do.

For a free pre-upload diagnostic, use the CID manuscript fit check.

Last verified: CID author guidance, OUP ScholarOne portal at mc.manuscriptcentral.com/cid, and OUP author portal.

The CID reviewer experience

Reviewer focus area
What CID asks reviewers to evaluate
How to prepare
Clinical-ID relevance
Does the finding affect ID practice or interpretation?
Frame around a specific clinical-ID decision
Methodology rigor
Are diagnostic, therapeutic, or epidemiological methods sound?
Document methods carefully, include power calculations
Reporting-checklist compliance
CONSORT/STROBE/PRISMA/STARD where applicable
Attach completed checklist as supplementary
Generalist-ID readership
Does this matter to ID clinicians beyond one disease?
Anchor discussion to broader ID principles
Reproducibility
Could another team reproduce this work?
Provide detailed methods and data-sharing plan

In our pre-submission review work with CID manuscripts

Three failure patterns generate the most consistent rejections.

Sub-disease specialty framing without generalist-ID translation. CID publishes for clinical ID broadly. Narrow disease focus without broader implications gets desk-rejected.

Reporting-checklist gaps. STROBE for observational, CONSORT for trials, STARD for diagnostic accuracy — must be attached and addressed.

Clinical-decision impact unclear. Reviewers want to know what specific clinical decision changes. The fix is to anchor the discussion to that decision explicitly.

Methodology note

This page was created from CID's public author guidance, OUP ScholarOne documentation, and Manusights review work.

Frequently asked questions

Your manuscript has cleared OUP ScholarOne admin checks and is being evaluated, either by the handling editor or by external peer reviewers. CID treats 'Under Review' as the active editorial period.

CID reports a median first-decision time of 4 to 8 weeks. Desk decisions usually arrive within 1 to 2 weeks; full peer-review decisions land 6 to 12 weeks after submission.

Wait at least 8 weeks before inquiring. Contact the editorial office through the OUP author portal, referencing the manuscript ID.

Your paper passed the desk screen and reviewers are committed. CID typically invites two to three reviewers including an ID clinician and a methodologist.

Yes. The 4 to 8 week median means roughly half of papers take longer. Clinical-trial submissions extend the timeline.

Past 10 weeks is the right moment for a polite, factual inquiry. Past 14 weeks suggests a reviewer dropped out. Silence in the first 5 weeks is normal.

References

Sources

  1. Clinical Infectious Diseases author guidelines
  2. OUP ScholarOne submission portal
  3. OUP editorial policies

Best next step

Use this page to interpret the status and choose the next sensible move.

For Clinical Infectious Diseases, the better next step is guidance on timing, follow-up, and what to do while the manuscript is still in the system. Save the Free Readiness Scan for the next paper you have not submitted yet.

Guidance first. Use the scan for the next manuscript.

Anthropic Privacy Partner. Zero-retention manuscript processing.

Internal navigation

Where to go next

Open Status Guide